Meta-Analysis
Copyright ©The Author(s) 2017.
World J Cardiol. Dec 26, 2017; 9(12): 830-837
Published online Dec 26, 2017. doi: 10.4330/wjc.v9.i12.830
Figure 1
Figure 1 Process of study selection for randomized and prospective trials (PRISMA Statement).
Figure 2
Figure 2 Forest plot demonstrating the primary and secondary outcomes in patients with out of hospital cardiac arrest who received erythropoietin compared to no erythropoietin group. A: Primary Outcomes: Brain death or CPC score 5; B: Secondary outcome: CPC score 1, and 2-4; C: Secondary outcome: Thrombotic events and acute stent thrombosis.